Publication:
Increasing rates of hbsag clearance and seroconversion in patients with hbeag-negative disease treated with peginterferon alfa-2a +/- lamivudine: Results of 5-year post-treatment follow up

dc.contributor.authorMarcellin, Patrick
dc.contributor.authorPiratvisuth, Teerha
dc.contributor.authorBrunetto, Maurizia
dc.contributor.authorBonino, F.
dc.contributor.authorLau, George
dc.contributor.authorFarci, Patrizia
dc.contributor.authorYurdaydın, Cihan
dc.contributor.authorWu, J.
dc.contributor.authorPopescu, Matei
dc.contributor.buuauthorGürel, Selim
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentİç Hastalıkları Ana Bilim Dalı
dc.contributor.departmentGastroenteroloji Bilim Dalı
dc.date.accessioned2022-06-09T05:58:02Z
dc.date.available2022-06-09T05:58:02Z
dc.date.issued2009
dc.descriptionBu çalışma, 22-26 Nisan 2009 tarihleri arasında Copenhagen[Danimarka]’da düzenlenen 44. Annual Meeting of the European-Association-for-the-Study-of-the-Liver’da bildiri olarak sunulmuştur.
dc.description.sponsorshipEuropean Assoc Study Liver
dc.identifier.citationMarcellin, P. vd. (2009) "Increasing rates of hbsag clearance and seroconversion in patients with hbeag-negative disease treated with peginterferon alfa-2a +/- lamivudine: Results of 5-year post-treatment follow up". Journal of Hepatology, 50(Supplement 1), S336-S336.
dc.identifier.endpageS336
dc.identifier.issn0168-8278
dc.identifier.issueSupplement 1
dc.identifier.startpageS336
dc.identifier.urihttp://hdl.handle.net/11452/26980
dc.identifier.volume50
dc.identifier.wos000266384701407
dc.indexed.wosSCIE
dc.indexed.wosCPCIS
dc.language.isoen
dc.publisherElsevier
dc.relation.collaborationYurt içi
dc.relation.collaborationYurt dışı
dc.relation.journalJournal of Hepatology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectGastroenterology & hepatology
dc.subject.wosGastroenterology & hepatology
dc.titleIncreasing rates of hbsag clearance and seroconversion in patients with hbeag-negative disease treated with peginterferon alfa-2a +/- lamivudine: Results of 5-year post-treatment follow up
dc.typeArticle
dc.wos.quartileQ1
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/İç Hastalıkları Ana Bilim Dalı/Gastroenteroloji Bilim Dalı
local.indexed.atWOS

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: